Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Akeso
Pharma
Roche-Hanmi, Akeso, a congressman's concerns—Fierce Pharma Asia
Roche signed an obesity deal with Hanmi. Akeso CEO defends ivonescimab's NSCLC data. A U.S. congressman says China is "beating us on our ground game."
Angus Liu
Aug 28, 2026 9:00am
Akeso CEO touts biliary tract win, counters ivonescimab debate
Aug 26, 2026 11:11am
Legend Biotech, Taiho-Cullinan, WuXi AppTec—Fierce Pharma Asia
Aug 14, 2026 8:52am
Summit updates ivonescimab survival data ahead of PDUFA
Jul 22, 2026 10:58am
Behind the headlines of ASCO 2026
Jun 5, 2026 9:38am
At ASCO, China biotech industry cements its coming of age
Jun 3, 2026 8:50am
